Works matching IS 0008543X AND DT 2019 AND VI 125 AND IP 10


Results: 35
    1

    Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

    Published in:
    2019
    By:
    • Gill, Harinder;
    • Kumana, Cyrus R;
    • Yim, Rita;
    • Hwang, Yu-Yan;
    • Chan, Thomas S Y;
    • Yip, Sze-Fai;
    • Lee, Harold K K;
    • Mak, Vivien;
    • Lau, June S M;
    • Chan, Chi-Chung;
    • Kho, Bonnie;
    • Wong, Raymond S M;
    • Li, Wa;
    • Lin, Shek-Yin;
    • Lau, Chi-Kuen;
    • Ip, Ho-Wan;
    • Leung, Rock Y Y;
    • Lam, Clarence C K;
    • Kwong, Yok-Lam
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    11
    14
    15
    16

    Errata.

    Published in:
    2019
    Publication type:
    corrected article
    17

    The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 10, p. 1674, doi. 10.1002/cncr.31977
    By:
    • D'Adda, Mariella;
    • Farina, Mirko;
    • Schieppati, Francesca;
    • Borlenghi, Erika;
    • Bottelli, Chiara;
    • Cerqui, Elisa;
    • Ferrari, Samantha;
    • Gramegna, Doriana;
    • Pagani, Chiara;
    • Passi, Angela;
    • Maifredi, Adriana;
    • Tucci, Alessandra;
    • Capucci, Maria A.;
    • Ruggeri, Giuseppina;
    • Rossi, Giuseppe
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Errata.

    Published in:
    2019
    Publication type:
    corrected article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35